No body fits in the test tube – the case of transthyretin
Authors:
- 8 September 2024
- journal article
- letter
- Published by Taylor & Francis in Amyloid
- Vol. 31 (4) , 347-349
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyNew England Journal of Medicine, 2024
- Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid CardiomyopathyJACC: Cardiooncology, 2021
- Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosisAmyloid, 2021
- Starting at the beginning: endoplasmic reticulum proteostasis and systemic amyloid diseaseBiochemical Journal, 2020
- Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- and Long-Distance Conformational ChangesJournal of Medicinal Chemistry, 2019
- Endoplasmic Reticulum Proteostasis Influences the Oligomeric State of an Amyloidogenic Protein Secreted from Mammalian CellsCell Chemical Biology, 2016
- Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit ExchangeBiochemistry, 2014
- Kinetic Stabilization of an Oligomeric Protein under Physiological Conditions Demonstrated by a Lack of Subunit Exchange: Implications for Transthyretin AmyloidosisBiochemistry, 2005
- Internalization of TransthyretinJournal of Biological Chemistry, 2001
- Serum Prealbumin and Retinol-Binding Protein Concentrations in Japanese-Type Familial Amyloid PolyneuropathyEuropean Neurology, 1988